Status | Study |
RECRUITING |
Study Name: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2021-07-20 Interventions: Pharmaceutically manufactured cannabidiol formulated as a clear gel that can be applied to the skin (transdermal delivery) |
Not yet recruiting |
Study Name: An Initial Study of AZD7325 in Adults With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2017-04-17 Interventions: Drug: AZD7325 (High-Dose) 15mg |
Recruiting |
Study Name: Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2016-01-25 Interventions: Drug: Minocycline, then Minocycline/Lovastatin |
Completed |
Study Name: Decisional Capacity and Informed Consent in Fragile X Syndrome Condition: Fragile X Syndrome (FXS) Date: 2015-05-22 Interventions: Other: Paper-Based Informed Consent |
Completed |
Study Name: A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2014-04-29 Interventions: Drug: MG01CI extended-release tablet Metadoxine, MG01CI extended-release tablet taken for 6 weeks treatm |
Recruiting |
Study Name: Study of Acamprosate in Fragile x Syndrome Condition: Fragile X Syndrome Date: 2013-07-26 Interventions: Drug: acamprosate Other Name: |
Completed |
Study Name: A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2013-07-03 Interventions: Drug: NNZ-2566 Glycyl-L-2-Meth |
Active, not recruiting |
Study Name: Ganaxolone Treatment in Children With Fragile X Syndrome Condition: Fragile x Syndrome Date: 2012-11-07 Interventions: Drug: Ganaxolone oral suspensi |
Terminated |
Study Name: An Open Label Extension Study in Subjects With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2012-03-01 Interventions: Drug: arbaclofen A flexible dose titration will be utilized. Orally disintegrating tablets |
Completed |
Study Name: Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS) Condition: Fragile X Syndrome Date: 2011-11-21 Interventions: Drug: AFQ056 |